Efavirenz is an enzyme inducer, which means it speeds up the breakdown of other medicines and lowers their levels. That is the opposite of what boosters do, and it creates a different and equally long list of problems.
How does induction work?
Efavirenz increases production of liver enzymes including CYP3A4. With more enzyme available, drugs handled by it are cleared faster and their levels fall, potentially below what is needed to work.
Why is that harder to spot?
Because a drug that is not working produces no dramatic symptom. A raised level causes toxicity you notice; a lowered level causes a contraceptive to fail or an antidepressant to stop helping, which is easily attributed to something else.
What about contraception?
The most consequential one. Efavirenz can reduce the effectiveness of some hormonal contraceptives, including implants and combined pills. Anyone who could become pregnant needs their method reviewed rather than assumed reliable.
Does that include trans men on testosterone?
The pregnancy risk applies to anyone with a uterus and ovaries who is having sex that could result in pregnancy, since testosterone is not contraception. If contraception is relevant to you, this interaction is relevant too.
What about gender-affirming hormone therapy?
Efavirenz can lower oestradiol levels through the same mechanism. This is worth checking and monitoring rather than assuming, and it is a reasonable argument for a different antiretroviral where hormone therapy is involved.
What about methadone?
Efavirenz substantially reduces methadone levels and can precipitate withdrawal. Anyone on a methadone programme needs both prescribers informed, since a dose increase is frequently required.
What about statins?
Levels of some statins are reduced, which matters because efavirenz also raises cholesterol. The combination can mean a statin that appears adequate is not doing enough, and doses may need adjusting upward.
What about anticonvulsants?
Several interact in both directions, with efavirenz reducing their levels and some of them reducing efavirenz. Any anticonvulsant needs specific checking rather than being assumed compatible.
What about hepatitis C treatment?
Efavirenz reduces levels of several direct-acting antivirals enough to compromise cure rates. Where hepatitis C treatment is planned, the HIV regimen is frequently changed first, which is straightforward and worth raising early.
What about St John's wort?
Contraindicated. It is itself an enzyme inducer and combining the two reduces efavirenz levels enough to risk failure and resistance.
What about recreational drugs?
Levels of some are reduced rather than raised, which is a different risk: people take more to achieve an effect and the interaction is unpredictable. Efavirenz does not carry the acute danger that boosters do with stimulants.
What about sedatives and anaesthesia?
Worth mentioning before any procedure, since induction can affect how sedatives and anaesthetic agents behave. Tell the team what you take rather than assuming they will see it.
How do you check a combination?
The University of Liverpool interaction checker covers antiretrovirals against prescription, over-the-counter and recreational drugs. With efavirenz, checking anything new is worth doing because reduced effectiveness is easy to miss.
Who should know what you take?
Any prescriber, any pharmacy, your dentist and anyone providing contraception. None of them see your HIV record automatically, and the contraception point in particular is one nobody will raise unless you do.
Who should know what you take?
Any prescriber, any pharmacy, your dentist and any hospital team. None of them see your HIV record automatically, so nobody will flag an interaction with efavirenz unless you mention it. A photograph of your packaging makes this quicker.
What if an interaction cannot be avoided?
Sometimes another condition genuinely needs a clashing drug. The answer is usually to change the HIV regimen rather than leave the other condition untreated, and that is worth raising rather than accepting a compromise.
What about emergencies?
Emergency treatment should not be delayed to check an interaction. Tell the team what you take, let them treat you, and have the combination reviewed afterwards rather than declining necessary care.